Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2399 |
Bortezomib
Radiciol,NSC 681239,硼替佐米,MG 341,DPBA,Brotezamide,LDP 341 |
Apoptosis; NF-κB; Proteasome; Autophagy | Apoptosis; Autophagy; NF-κB; Proteases/Proteasome; Ubiquitination |
Bortezomib (LDP 341) 是一种 20S 蛋白酶体抑制剂 (Ki=0.6 nM),具有可逆性和选择性。Bortezomib 具有抗肿瘤活性,可以抑制 NF-κB,可破坏细胞周期、诱导细胞凋亡。 | |||
T37581 | SCIO 469 hydrochloride | ||
Selective, ATP-competitive p38 inhibitor (IC50 = 9 nM for p38α in vitro). Displays approximately 10-fold selectivity for p38α over p38β and 2000-fold selectivity for p38α over 20 other kinases. Reduces p38α phosphorylation in multiple myeloma cells in vitro and in vivo; activity results in decreased tumor burden and angiogenesis in murine models of multiple myeloma. Also enhances bortezomib-induced cytotoxicity against multiple myeloma cells. Hideshima et al (2004) p38 MAPK inhibition enhances P... |